It has been reported that dopaminergic stimulation by treatment with levodopa and a dopa-decarboxylase inhibitor improved motor activities, such as tremor, hindlimb clasping, gait, mobility and breathing, in a Mecp2 mouse model [24]. This evidence concerns the gene MECP2 and Tremor.